Companies /Healthcare

Veeva Systems Inc - Class A

NYSE: VEEV Health Information Services
$285.10
â–² $40.19 (+16.41%) today
Markets open · 2:31pm ET

Q1 2027 Earnings

Reported Jun 3, 2026, 4:04pm ET · SEC source
$2.24
Beat +4.91%
EPS · est. $2.14
$882.9M
Beat +2.94%
Revenue · est. $857.7M
+6.9%
Beating market
VEEV vs S&P since report
7 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−9%−6%−3%0Jun 3Jun 4report 4:04pm ETearnings+0.2%−2.7%
−9%−6%−3%0Jun 3Jun 4earnings+0.2%−2.7%
VEEV −2.7%S&P 500 +0.2%
−9%−6%−3%0Jun 3Jun 4report 4:04pm ETearnings−0.9%−2.7%
−9%−6%−3%0Jun 3Jun 4earnings−0.9%−2.7%
VEEV −2.7%NASDAQ −0.9%
−4%0+4%+8%Jun 2Jun 11report 4:04pm ETearnings−1.8%−4.9%
−4%0+4%+8%Jun 2Jun 11earnings−1.8%−4.9%
VEEV −4.9%S&P 500 −1.8%
−5%0+5%Jun 2Jun 11report 4:04pm ETearnings−3.4%−4.9%
−5%0+5%Jun 2Jun 11earnings−3.4%−4.9%
VEEV −4.9%NASDAQ −3.4%
−0.07%
Day of report
−3.35%
Next session
−9.55%
One week
+5.36%
30 days

S&P 500 over the same 30 days: −1.54%.

Did VEEV Beat Earnings? Q1 2027 Results

Veeva Systems delivered a strong fiscal first quarter of 2027, beating Wall Street expectations on both the top and bottom lines as its accelerating AI strategy helped drive broad-based demand across its life sciences cloud platforms. The clinical and commercial software maker posted non-GAAP EPS of $2.24, ahead of the $2.14 consensus estimate by 4.91%, marking the fifth consecutive quarter of beating EPS expectations. Revenue climbed 16.3% year over year to $882.95 million, topping the $857.73 million consensus by 2.94%, with subscription revenues of $730.17 million anchoring the result. The quarter's defining story was Veeva's deliberate pivot toward agentic AI, with CEO Peter Gassner repositioning the company as an "industry-specific application and AI agent company," a strategic shift that analysts see underpinning a compelling long-term growth setup. Operating cash flow surged to $1.13 billion, and the company raised its full-year fiscal 2027 revenue guidance to $3.64 billion at the midpoint, while projecting non-GAAP EPS of approximately $9.05 and second-quarter revenue of $902 to $905 million.

Key Takeaways
  • Subscription revenue growth of 15% year over year driven by broad-based adoption
  • 27 new Vault CRM customers added in the quarter, now more than 150 customers live
  • Multiple enterprise biopharma wins across clinical, regulatory, and safety in Development Cloud
  • Strong operating cash flow of $1.127 billion in the quarter

“Our rapid progress with Veeva AI sets the foundation as we enter the next chapter of our industry cloud.”

Veeva Systems CEO, on the earnings call

Forward Guidance & Outlook

For fiscal Q2 2027 (ending July 31, 2026), Veeva guided total revenues of $902–$905 million, non-GAAP operating income of $392–$395 million, and non-GAAP diluted EPS of $2.21–$2.22. For the full fiscal year 2027 (ending January 31, 2027), the company raised guidance to total revenues of $3,635–$3,645 million, non-GAAP operating income of approximately $1,610 million, and non-GAAP diluted EPS of approximately $9.05.

VEEV YoY Financials

Q1 2027 vs Q1 2026 · SEC filings Q1 2026 Q1 2027
$0$300.0M$600.0M$900.0M$759.1M$882.9MRevenue$585.2M$662.0MGross Profit$233.7M$273.1MOperating Income$228.2M$260.9MNet Income
$0$300.0M$600.0M$900.0MRevenueGross ProfitOperating IncomeNet Income

VEEV Revenue by Segment

Subscription Services$730.2M+15.0%
Veeva R&D Solutions - Subscription$392.3M+19.1%
Veeva Commercial Solutions - Subscription$337.9M+10.6%
Professional Services and Other$152.8M+22.9%
Veeva R&D Solutions - Professional Services$95.2M+22.5%
Veeva Commercial Solutions - Professional Services$57.6M+23.6%

Figures from SEC filings and company reports. Not investment advice.